Backgroud/Aims: Previous studies have shown that miR-501 is involved in the development of hepatocellular carcinoma (HCC) by promoting cell proliferation through CYLD. From the published MirSNP database that enrolls all single nucleotide polymorphisms(SNPs) of microRNA (miRNA), we found an interesting SNP (rs112489955, G>A) located in the mature region of miR-501. Methods: We performed a case-control study focusing on the predicted SNP located in miRNA-501 to investigate the further relationship of the SNPs with miRNAs among HCC patients. Genotyping, real time PCR assay, cell transfection and the dual luciferase reporter assay were used in our study. Results: Bioinformatic analysis indicated that this SNP would inhibit the binding of miR-501 to CYLD. In a case-control study, subjects with the variant genotypes (AG, GG) showed a significantly increased risk of HCC relative to AA carriers. A significant association of miR-501 variant genotypes with enhanced tumor growth was also observed. Further functional analyses indicated that patients with the AA genotype might attenuate the level of CYLD compared to that regulated by miR-501 with the GG genotype. A dual luciferase reporter assay also confirmed that miR-501 with the A allele had reduced binding to CYLD. We further confirmed a suppression of cell proliferation and promotion of apoptosis in SMMC-7721 and Hep3B cell lines treated with the AA genotype. Conclusions: We identified a novel SNP located in miR-501 acting as an important factor of the HCC susceptibility by modulating miR-501 and CYLD levels.
Introduction
Hepatocellular carcinoma (HCC) accounts for 70%-90% of primary liver cancer, which has emerged as the fifth most common cancer and the second leading cause of cancer-related deaths worldwide [1, 2] .It is characterized by delayed diagnosis and poor prognosis [3, 4] . With the development of high-throughput sequencing, it has been identified that the pathogenesis of HCC is highly associated with genetic factors, environmental factors, hepatitis B virus infection, as well as abnormal activation of signaling pathways [5] [6] [7] . Various single nucleotide polymorphisms (SNPs), as well as mutations, in protein-coding genes are involved in the development of HCC [8, 9] . However, the SNPs or mutations located in noncoding RNA in HCC have not been investigated thoroughly.
Non-coding RNA, mainly including microRNA (miRNA) and long non-coding RNA, has been reported to play an important role in HCC by interacting with protein-coding genes, resulting in abnormal cell proliferation, invasion, differentiation, cell cycle changes or apoptosis [10] [11] [12] [13] . Among these, miRNA was found to regulate negatively post-transcriptional gene expression by cleaving target mRNA or by inhibiting their translation [14] [15] [16] . For example, miR-145 acts as a tumor suppressor and its downregulation in tumor tissues may contribute to the progression and metastasis of HCC through a mechanism involving ROCK1, suggesting that miR-145 is a potential new diagnostic and therapeutic target for the treatment of HCC [17] . In addition, increasing evidence indicates that SNPs or mutations could make a significant contribution during the regulation of miRNA. MiR-27a, a genetic variant could contribute to gastric cancer susceptibility by affecting miR-27a and target gene expression,whereas miR-608 rs4919510 is associated with the prognosis of HCC [18, 19] .
In this study, as a continuation of published research that identified that miR-501 regulates ubiquitin carboxyl-terminal hydrolase(CYLD) expression and promotes cell proliferation in human HCC, we focused on the SNP (rs112489955, G>A) located in the mature region of miR-501, based on the public database miRNA SNP (http://www.bioguo. org/miRNASNP/) that includes all the SNPs located in miRNAs [20, 21] . We further performed a case-control study to investigate whether this SNP in miR-501 is associated with the development of HCC or causes an abnormal regulation of CYLD.
Materials and Methods

Patient samples
Six-hundred and ninety-five patients with HCC and 605 healthy controls were enrolled in this study. Blood samples from both HCC patients and healthy controls were obtained from the First Affiliated Hospital of Nanjing Medical University (Nanjing, China). Informed consent for blood analysis was obtained prior to surgery. Experiments were undertaken with the understanding and written consent of each subject. Peripheral blood was collected before surgery. HCC cases were confirmed by histopathological analysis. The health of control individuals was confirmed by the absence of any malignant tumors, hereditary disease or autoimmune disease.This study was approved by the Institutional Review Board of Nanjing Medical University. All research was performed in compliance with government policies and the Helsinki Declaration.
Genotyping
Genomic DNA was isolated from the blood samples according to standard phenol and chloroform extraction procedures. The Taqman probe was used to detect the distribution of the genotype in all cases. The probe targeting the SNP (rs112489955) was purchased from Applied Biosystems (Life Technologies, CA, USA; Catalog # 4351379). The polymerase chain reaction (PCR) assay was performed using an ABI 7900HT Real Time PCR instrument, as described by the manufacturer's instructions.
Cell culture
Human HCC cell lines, HepG2, SMMC-7721, MHCC-97H, SNU423, Huh7 and Hep3B, were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). They were maintained in an atmosphere of 5 % CO 2 in Dulbecco's modified eagle's medium (Thermo, Beijing,China) supplemented with 10% fetal bovine serum (Thermo,Beijing,China). Cell line authentication was performed by STR profiling before the initiation of the project. 
Quantitative real time polymerase chain reaction (qRT-PCR)
QRT-PCR was performed to determine the expression levels of miRNA-501 and CYLD of all related genes. Total RNA was obtained from tissues using TRIzol reagent, as described by the manufacturer (Invitrogen Life Technologies, CA, USA). The Taqman probe targeting miR-501 was obtained from ABI (Catalog # A25576). U6 snRNA was used as an internal control. The primers for detecting the expression of CYLD were 5ʹ-TCAGGCTTATGGAGCCAAGAA-3ʹand 5ʹ-ACTTCCCTTCGGTACTTTAAGGA-3ʹ.QRT-PCR was performed using an ABI Prism 7900HT instrument (Applied Biosystems) according to the directions provided with the reagents [22] .
Luciferase reporter gene assay
The 3ʹ-UTR sequence of CYLD predicted to interact with miR-501 (either with the GG genotype or with the AA genotype) or a mutated sequence with the predicted target sites were inserted into the pGL4 promoter vector. For reporter assay, cells were plated onto 24-well plates. A Renilla luciferase vector pRL-SV40 (5 ng) was also co-transfected to normalize the differences in transfection efficiency.
Cell proliferation assays and cell apoptosis detection
The proliferative ability of HCC cell lines was detected by the EDU cell proliferation assay (Millipore, MA, USA). In brief, cells transfected with miR-501 mimics with different genotypes or controls were seeded at a density of 1 × 10 4 cells/well in flat-bottom 96-well plates and cultured for 48 h. The absorbance values measured at 450 nm represent the rate of DNA synthesis following the EDU stain, and correspond to the number of proliferating cells.
For the apoptosis analysis, cells were washed in PBS, and then processed with Annexin V-FITC-PI Apoptosis Detection Kit (BD Biopharmingen, NJ, USA) for 15 min in the dark. All experiments were analyzed by BD Biasciences FACS Calibur Flow Cytometry (BD Biasciences, NJ, USA). The tests were repeated for three times with triplicate per experiment as described [13] .
Statistical methods
All experiments were repeated independently at least three times. Data are expressed as the mean ± SD. Differences between two independent groups were tested with Student's t-test. All statistical analyses were performed with Stata10.0 software, and are presented with GraphPad prism software. The results were considered to be statistically significant at P<0.05.
Results
SNP (rs112489955) is associated with the risk of HCC
We first calculated whether the SNP (rs112489955) located in the mature region of miR-501 would cause an abnormal hairpin structure. As presented in Fig. 1A , bioinformatic analysis revealed that the miR-501 with the AA genotype would develop another stem-loop in the hairpin structure. Further analysis predicted that miR-501 with the GG genotype could directly bind to the 3' UTR region of CYLD with the minimum free energy of -25kcal/mol, Table 2 . The genotype of the ploymorphisms rs112489955 in HCC patients and cancer-free controls.
a The ORs, 95% CIs and P value were calculated after adjusting for age, gender Table 3 . The stratified analysis of association between rs112489955 and HCC risk. *Two-sided chi-square test for either genotype distributions or allele frequencies between cases and controls indicating that the SNP located in miR-501 might be associated with the binding between miR-501 and CYLD (Fig. 1B) .
Based on the aforementioned prediction results, we next conducted the genotype assay to detect the distribution of SNP (rs112489955) in a case-control study. All the individuals enrolled in the case group and control groups were age-and gender-matched ( Table 1) . The exposure to alcohol and smoking was calculated to be at the same level in the two groups. There was also no difference between the case and control subjects in terms of hypertension or diabetes mellitus, indicating that the match of controls and cases was adequate. Further genotype detection showed that the distribution of the GG genotype in cases (69.7%) was higher than in control groups(53.2%), whereas the A alleles in cases (39.3%) was lower than that in the control group(46.8%). Taking the GG genotype as a reference, the difference in rs112489955 genotype distributions between the cases and controls was statistically significant(P = 0.007), and the distribution of the A allele in the two groups was also significantly different (P<0.001). The genotype distribution in the cases and controls was in agreement with the Hardy-Weinberg equilibrium (Table 2) .
SNP (rs112489955) is associated with tumor growth
According to a previous report, miR-501 is associated with the proliferation of HCC cell lines by regulating CYLD. We therefore analyzed the association of different genotypes of miR-501 with different clinical characteristics of HCC patients. As presented in Table 3 , the tumor differentiation grade, tumor number, tumor size, tumor capsular and metastasis information was collected. We found that patients with GG genotype presented with a larger tumor size compared to patients with GA or AA genotypes. However, no difference was obtained in other subgroups, indicating that the SNP rs112489955 might be associated with cell proliferation through a CYLD-dependent pathway.
The basal expression of miR-501 in human HCC cell lines, including HepG2, SMMC-7721, MHCC-97H, SNU423, Huh7 and Hep3B was measured. For the next step, we selected SMMC-7721 and Hep3B cell lines (Fig. 2A) . We first detect the expression of CYLD mRNA in the two cells transfected with miR-501 with different genotypes. We found that the expression of CYLD in cells treated with wild type miR-501 was decreased compared with the SNP 
Discussion
In the present study, we found that the common polymorphisms within miR-501 (rs112489955) are associated with a significantly decreased risk of HCC. Preliminary functional assays revealed that the miR-polymorphism conferred an increased level of CYLD as a result of the diminished binding to CYLD. We also found that the SNP located in the mature region of miR-501 might cause suppressed cell proliferation as compared with the wild type.
CYLD, a deubiquitination enzyme, functions as a tumor suppressor in different types of cancer, such as melanoma, and basal cell, colon and HCCs [23] [24] [25] [26] . CYLD can translocate to the perinuclear region and bind the IκB family member Bcl-3, and removes K63-linked poly ubiquitin chains upon stimulation. This prevents the nuclear translocation of Bcl-3-p50 and Bcl-3-p52 complexes [27, 28] . In addition, downregulation of CYLD induces tumor cell
